The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Abemaciclib in recurrent/metastatic head and neck squamous cell carcinoma (RM-HNSCC) harboring CDKN2A loss, and/or CCND1 and/or CDK6 amplification: A phase II multicenter trial.
 
Jerome Fayette
Honoraria - AstraZeneca; Bristol-Myers Squibb; Hookipa Pharma; Merck Serono; Merck Sharp & Dohme; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Elevar Therapeutics; Hookipa Pharma; ITeos Therapeutics; Merck Serono; Merck Sharp & Dohme; Seagen
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme
 
Esma Saada-Bouzid
No Relationships to Disclose
 
Claire Cropet
No Relationships to Disclose
 
Amaury Daste
Consulting or Advisory Role - BMS; Merck; MSD
Travel, Accommodations, Expenses - BMS; Merck
 
Isabelle Treilleux
No Relationships to Disclose
 
Daniel Pissaloux
No Relationships to Disclose
 
Frank Pilleul
No Relationships to Disclose
 
Charles Mastier
No Relationships to Disclose
 
Eve-Marie Neidhardt
No Relationships to Disclose
 
Andy Karabajakian
No Relationships to Disclose
 
Elodie Grinand
No Relationships to Disclose
 
Romaine Mayet
No Relationships to Disclose
 
Mathilde Bernardin
No Relationships to Disclose
 
Clothilde Celse
No Relationships to Disclose
 
Gwenaelle Garin
No Relationships to Disclose
 
David Pérol
Honoraria - AstraZeneca; BMS; DAIICHI SANKYO; Lilly; MSD; Novartis; Roche; TAKEDA
Travel, Accommodations, Expenses - Roche